AVEO Pharmaceuticals, Inc. withdraws earnings guidance for the year 2022. Due to the pending transaction, the company will not host a conference call to discuss its quarterly financial results and withdraws its previously issued financial guidance for fiscal year 2022, last updated on August 4, 2022.
1st Jan change | Capi. | |
---|---|---|
-2.39% | 88.91B | |
+2.76% | 41.25B | |
-13.92% | 31.99B | |
+50.51% | 24.73B | |
-15.25% | 15.54B | |
-39.93% | 12.07B | |
-9.08% | 12.05B | |
-14.80% | 12.02B | |
+6.22% | 8.84B |